Home MelangeHealth Neurocrine Biosciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Neurocrine Biosciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

by PrittlePrattleNews

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Goldman Sachs 42nd Annual Global Healthcare Conference at 1:20 p.m. Eastern Time on Tuesday, June 8, 2021. Kevin Gorman, Chief Executive Officer, will present at the conference.

 

The live presentation will be webcast and may be accessed on the Company’s website under Investors at www.neurocrine.com. A replay of the presentation will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month.

About Neurocrine Biosciences

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.

 

This article is shared with Prittle Prattle News in the form of a Press Release.

Disclaimer: The following Press Release comes to you under a network of a strategic syndication partnership with PR Newswire. Prittle Prattle News takes no editorial responsibility for the same.

Also read ShortsTV and Amazon Collaborate

rt

You may also like

Our Company

Prittle Prattle News also known as PP News, is an internationally most reliable business online news portal – prittleprattlenews is among trusted, respected, and fastest-growing online news portals. 

@2021 – All Right Reserved. Designed and Developed by Prittle Prattle